CN102100817A - Chinese medicinal preparation for treating infection of upper respiratory tracts - Google Patents
Chinese medicinal preparation for treating infection of upper respiratory tracts Download PDFInfo
- Publication number
- CN102100817A CN102100817A CN2010105634838A CN201010563483A CN102100817A CN 102100817 A CN102100817 A CN 102100817A CN 2010105634838 A CN2010105634838 A CN 2010105634838A CN 201010563483 A CN201010563483 A CN 201010563483A CN 102100817 A CN102100817 A CN 102100817A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicinal
- upper respiratory
- medicinal preparation
- respiratory tracts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a Chinese medicinal preparation for treating the infection of upper respiratory tracts, which comprises the selected raw material medicaments: mongolian dandelion herb, bupleurum, Indian buead, astragalus, largehead atractylodes rhizome, divaricate saposhnikovia root, cassia twig, pinellia tuber and liquoric root. The selected medicinal medicaments have the effects of relieving exterior syndrome by diaphoresis, warming channels, warming dryness and reducing phlegm, lower adverse qi and arresting vomiting and dissolving lumps and resolving masses. The immunologic function of organisms is improved by oral administration, so the Chinese medicinal preparation has excellent curative effect on the infection of upper respiratory tracts caused by various reasons. According to clinical application, the Chinese medicinal preparation has the advantages of quick response, obvious treatment effect, high tolerance, low cost and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation that is used for the treatment of upper respiratory tract infection.
Background technology
It is modal infectious disease to the acutely inflamed general name between the throat that upper respiratory tract infection means from nasal cavity.Cause by virus about 90% that bacterial infection often is secondary to after the viral infection.The primary disease four seasons, any age all can fall ill, and by containing the spittle, the droplet of virus, or propagate through the apparatus that pollutes.Often when Abwehrkraft des Koepers reduces, as catch cold, tired, situation such as drench with rain, the former virus that has existed or invaded by the external world is or/and antibacterial, the ramp breeding causes infecting.Chang Jifa bronchitis, pneumonia, nasal sinusitis, a few peoples can concurrent acute myocarditis, nephritis, rheumatic fever etc.Clinical manifestation 1. Acute onset.2. pharyngeal discomfort, drying or pharyngalgia are arranged in early days, and that continues sneeze, watery nasal discharge, nasal obstruction, cough occur.3. can be with headache, heating, hoarseness, weak, limb aching pain, loss of appetite.4. obviously congested, the edema of nose, pharynx, larynx, submandibular lymph nodes enlargement, tenderness.The medicine of traditional Chinese medical herbal treatment has Antiphlogistic Powder of Schizonepetae and Ledebouriellae, fragrant Soviet Union drink etc.; Affection due to external wind and heat, but Lonicerae and Forsythiae Powder, SANGJU YIN etc.
Summary of the invention
The object of the present invention is to provide a kind ofly have that relieving the exterior syndrome by diaphoresis, promoting the flow of QI-blood by warming the meridian, dry temperature reduce phlegm, the Chinese medicine preparation of the effect of stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass, the upper respiratory tract infection that causes at a variety of causes has good efficacy.
The present invention has adopted following technical scheme:
The present invention has adopted following technical scheme: crude drug and the composition by weight thereof chosen are respectively: 12 parts of Herba Taraxacis, 8 parts of Radix Bupleuri, 10 parts in Poria, 10 parts of the Radixs Astragali, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Saposhnikoviaes, 3 parts of Ramulus Cinnamomi, 6 parts of the Rhizoma Pinelliaes, 3 parts in Radix Glycyrrhizae;
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations.For example these crude drug pulverize mix homogeneously powder can be taken after mixing it with water; Can be with these crude drug decocting together, concentrate decocting liquid then and take, perhaps concentrated decocting liquid is condensed into cream and is processed into pill and takes; Bring into play drug effect better for each raw material that makes this medicine, carry out special extraction at certain crude drug, as ethanol extraction, these can not be used to limit protection scope of the present invention.Active component of the present invention can add various conventional adjuvant required when preparing different dosage form, be prepared into any peroral dosage form commonly used as disintegrating agent, lubricant, binding agent etc. with the method for Chinese medicinal of routine, as pill, powder, tablet, capsule, oral liquid etc.
In the raw materials of traditional Chinese medicinal materials that the present invention chooses, its effect and pharmacological action are respectively:
Herba Taraxaci: heat-clearing and toxic substances removing, the eliminating carbuncle eliminating stagnation, dampness removing is treating stranguria.
Radix Bupleuri: induce sweat and bring down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.
Poria: promoting diuresis to eliminate damp pathogen, spleen invigorating is calmed the nerves.
The Radix Astragali: tonifying Qi and lifting yang, benefit is defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, inducing diuresis to remove edema.
The Rhizoma Atractylodis Macrocephalae: air making-up and spleen enlivening, the dampness diuretic, hidroschesis, antiabortive.
Radix Saposhnikoviae: expelling pathogenic wind from the body surface, win and wet, pain relieving, spasmolytic.
Ramulus Cinnamomi: relieving the exterior syndrome by diaphoresis, promoting the flow of QI-blood by warming the meridian, warm aid yang qi.
The Rhizoma Pinelliae: dry temperature is reduced phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.
Radix Glycyrrhizae: the QI invigorating invigorating middle warmer, expelling phlegm for arresting cough, detoxifcation, relieving spasm to stop pain relaxes the property of medicine.
Selected medical material plays altogether that relieving the exterior syndrome by diaphoresis, promoting the flow of QI-blood by warming the meridian, dry temperature reduce phlegm, the effect of stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.Improved human body immune function by for oral administration, the upper respiratory tract infection that causes at a variety of causes has good efficacy.Find through clinical practice, the present invention have effect rapidly, therapeutic effect obviously, better tolerance, advantage with low cost, without any side effects.
Use pill of the present invention, respectively obey a ball sooner or later, every ball 9-12 gram, 21 is a course of treatment, clinical patient's 676 examples of accepting for medical treatment, the rehabilitation case is 652 examples.
The specific embodiment
A kind of Chinese medicine preparation that is used for the treatment of upper respiratory tract infection of the present invention, crude drug and the composition by weight thereof chosen are respectively: 12 parts of Herba Taraxacis, 8 parts of Radix Bupleuri, 10 parts in Poria, 10 parts of the Radixs Astragali, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Saposhnikoviaes, 3 parts of Ramulus Cinnamomi, 6 parts of the Rhizoma Pinelliaes, 3 parts in Radix Glycyrrhizae;
Its preparation comprises pill, powder, tablet, oral liquid formulations, the capsule preparations that utilization conventional formulation technology or modern preparation process are made.
Claims (1)
1. Chinese medicine preparation that is used for the treatment of upper respiratory tract infection, it is characterized in that: crude drug and the composition by weight thereof chosen are respectively: 12 parts of Herba Taraxacis, 8 parts of Radix Bupleuri, 10 parts in Poria, 10 parts of the Radixs Astragali, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Saposhnikoviaes, 3 parts of Ramulus Cinnamomi, 6 parts of the Rhizoma Pinelliaes, 3 parts in Radix Glycyrrhizae; Its preparation comprises pill, powder, tablet, oral liquid formulations, the capsule preparations that utilization conventional formulation technology or modern preparation process are made.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105634838A CN102100817A (en) | 2010-11-29 | 2010-11-29 | Chinese medicinal preparation for treating infection of upper respiratory tracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105634838A CN102100817A (en) | 2010-11-29 | 2010-11-29 | Chinese medicinal preparation for treating infection of upper respiratory tracts |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102100817A true CN102100817A (en) | 2011-06-22 |
Family
ID=44154017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105634838A Pending CN102100817A (en) | 2010-11-29 | 2010-11-29 | Chinese medicinal preparation for treating infection of upper respiratory tracts |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102100817A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102416098A (en) * | 2011-12-07 | 2012-04-18 | 郑丽霞 | Medicament for treating upper respiratory tract infection |
CN103372161A (en) * | 2013-07-16 | 2013-10-30 | 彭安泽 | Medicament for treating bad cold |
CN103751357A (en) * | 2014-01-16 | 2014-04-30 | 于炳好 | Traditional Chinese medicine composition for treating spleen-deficiency-type colonitis |
CN103919983A (en) * | 2014-04-28 | 2014-07-16 | 河南安进生物医药技术有限公司 | Antiviral and antibacterial mixture for preventing and treating upper respiratory tract infection of livestock and poultry |
-
2010
- 2010-11-29 CN CN2010105634838A patent/CN102100817A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102416098A (en) * | 2011-12-07 | 2012-04-18 | 郑丽霞 | Medicament for treating upper respiratory tract infection |
CN102416098B (en) * | 2011-12-07 | 2014-03-26 | 郑丽霞 | Medicine preparation used for treating upper respiratory tract infection |
CN103372161A (en) * | 2013-07-16 | 2013-10-30 | 彭安泽 | Medicament for treating bad cold |
CN103751357A (en) * | 2014-01-16 | 2014-04-30 | 于炳好 | Traditional Chinese medicine composition for treating spleen-deficiency-type colonitis |
CN103751357B (en) * | 2014-01-16 | 2016-03-23 | 于炳好 | A kind of Chinese medicine composition for the treatment of spleen-deficient colitis |
CN103919983A (en) * | 2014-04-28 | 2014-07-16 | 河南安进生物医药技术有限公司 | Antiviral and antibacterial mixture for preventing and treating upper respiratory tract infection of livestock and poultry |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104436125A (en) | Traditional Chinese medicine for treating influenza and preparation method thereof | |
CN101926908B (en) | Traditional Chinese medicine composition for treating cold | |
CN103877517A (en) | Traditional Chinese medicine for treating pneumonia | |
CN102100817A (en) | Chinese medicinal preparation for treating infection of upper respiratory tracts | |
CN103006872B (en) | Chinese medicinal preparation for treating flu | |
CN103071120B (en) | Medicine for treating silicosis | |
CN101036706B (en) | Wine for promoting blood circulation, removing blood stasis and eliminating rheumatism | |
CN105381153A (en) | Traditional Chinese medicine preparation for treating bronchitis and preparation method thereof | |
CN103550715A (en) | Traditional Chinese medicine for treating bronchitis | |
CN101810741A (en) | Chinese medicament preparation for treating upper respiratory tract infection | |
CN105031087A (en) | Medical wine with effects of dispelling wind and removing dampness and manufacturing method of medical wine | |
CN101985009A (en) | Chinese medicinal composition for treating chronic urticaria | |
CN102552789A (en) | Chinese medicine for treating damp-warm flu and preparation method and application thereof | |
CN105641228A (en) | Traditional Chinese medicine decoction capable of effectively treating anemopyretic cold and preparation method | |
CN102100824A (en) | Traditional Chinese medicine for treating difficult urination | |
CN105012658A (en) | Drug with functions of eliminating swelling and relieving pain | |
CN103893632B (en) | One treats psoriasic Chinese medicine composition | |
CN103920118A (en) | Externally-used Chinese herbal medicine for treating neck-shoulder and lumbocrural pain, soreness, swelling and paralysis | |
CN104435122A (en) | Traditional Chinese medicine lotion for treating anaphylactic rhinitis | |
CN102100801A (en) | Traditional Chinese medicine for treating impotence | |
CN102100861A (en) | Chinese medicine for treating children fever of unknown origin | |
CN102100830A (en) | Chinese medicine for treating psoriasis | |
CN107789465A (en) | A kind of Chinese medicine composition for treating chronic dacryocystitis | |
CN107669867A (en) | A kind of preparation method for the Chinese medicine composition for treating chronic dacryocystitis | |
CN106237261A (en) | A kind of for decoction medicine treating gastric cancer and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110622 |